Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Biotecnika Times – Newsletter 25.01.2021 – CSIR Notice, CSIR-CCMB & ILS Hiring, FSSAI Funded